Patent Assignment
Reel/Frame 019161/0493
Change of Name
Recorded: 2007-04-16
Pages: 13
Assignor
BIOGEN, INC.
Executed: 2003-11-13
Assignee
BIOGEN IDEC MA INC.
14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(38)
Treatment for Insulin Dependent Diabetes
Patent:
5,888,507 →
Application:
08/447,118 →
Recombinant Anti-Vla-4 Antibody Molecules
Patent:
6,602,503 →
Application:
08/454,899 →
Method of Making and Binding Caip Polypeptides
Patent:
6,171,800 →
Application:
08/474,697 →
Caip-Like Gene Family
Patent:
5,641,748 →
Application:
08/475,894 →
The Caip-Like Gene Family
Patent:
5,837,844 →
Application:
08/484,709 →
Caip-Like Gene Family
Patent:
5,656,438 →
Application:
08/484,710 →
Treatment for Asthma with Vla-4 Blocking Agents
Patent:
5,871,734 →
Application:
08/822,830 →
Treatment for Inflammatory Bowel Disease
Patent:
5,932,214 →
Application:
08/950,660 →
Treatment for Inflammatory Bowel Disease with a Vcam-1/1GG Fusion Protein
Patent:
6,482,409 →
Application:
09/157,452 →
Ret Ligand (Retl) for Stimulating Neutral and Renal Growth
Patent:
6,677,135 →
Application:
09/187,906 →
Kidney Injury-Related Molecules
Patent:
6,664,385 →
Application:
09/197,970 →
Tumor Necrosis Factor Related Ligand
Patent:
7,129,061 →
Application:
09/245,198 →
Antibodies to Ret and RETL3
Patent:
6,861,509 →
Application:
09/489,407 →
Caip-Like Gene Family
Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
Application:
10/170,841 →
Publication:
US 2002/0197233
PanCAM nucleic acids and polypeptides
Application:
10/180,410 →
Publication:
US 2003/0148382
Method for Promoting Neovascularization
GP286 Nucleic Acids and Polypeptides
Application:
10/312,495 →
Publication:
US 2003/0165495
Gp354 nucleic acids and polypeptides
Application:
10/312,528 →
Publication:
US 2003/0211517
Tweak Receptor Agonists as Anti-Angiogenic Agents
Kidney Injury-Related Molecules
Application:
10/655,506 →
Publication:
US 2005/0089868
Ret ligand (RetL) for stimulating neural and renal growth
Application:
10/668,936 →
Publication:
US 2005/0080235
Method for promoting neovascularization
Application:
11/145,340 →
Publication:
US 2006/0003932
C-Ret Proto-Oncogene Binding Protein
Application:
60/017,427 →
Modulators of Tissue Regeneration
Application:
60/018,228 →
C-Ret Proto-Oncogene Binding Protein
Application:
60/019,300 →
C-Ret Proto-Oncogene Binding Protein
Application:
60/021,859 →
Modulators of Tissue Regeneration
Application:
60/023,442 →
C-Ret Proto-Oncogene Binding Protein
Application:
60/043,533 →
Renal regulatory elements and methods of use thereof
Application:
60/212,131 →
Polymer conjugates of neublastin and methods of using same
Application:
60/266,071 →
Molecules and methods for inhibiting shedding of KIM-1
Application:
60/295,449 →
Molecules and methods for inhibiting shedding of KIM-1
Application:
60/295,907 →
Detection of secreted polypeptides
Application:
60/382,795 →
Method for enhancing protein production by eukaryotic cells
Application:
60/391,738 →
KIM-1 antagonists and use to modulate immune system
Application:
60/436,934 →
Method for enhancing protein production by eukaryotic cells
Application:
60/440,498 →
Polymer-conjugated, glycosylated neublastin
Application:
60/463,899 →
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 13, 2005
From: JAKUBOWSKI, ANIELA; BURKLY, LINDA C.
To: BIOGEN IDEC MA INC.
Reel/Frame 016790/0255 →
Assignment of Assignor's Interest
Jun 8, 2006
From: LOBB, ROY R.; BURKLY, LINDA C.
To: BIOGEN, INC.
Reel/Frame 017759/0052 →
Assignment of Assignor's Interest
Oct 17, 2006
From: SANICOLA-NADEL, MICHELE; HESSION, CATHERINE; CATE, RICHARD L.; WEI, HENRY
To: BIOGEN, INC.
Reel/Frame 018401/0383 →
Assignment of Assignor's Interest
Oct 17, 2006
From: BONVENTRE, JOSEPH V.; ICHIMURA, TAKAHARU
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 018401/0811 →
Change of Name
Oct 24, 2006
From: BIOGEN, INC.
To: BIOGEN IDEC MA INC.
Reel/Frame 018428/0001 →
Change of Name
Dec 28, 2006
From: BIOGEN, INC.
To: BIOGEN IDEC MA, INC.
Reel/Frame 018696/0637 →
Assignment of Assignor's Interest
Apr 7, 2009
From: PODOLSKY, DANIEL
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 022513/0946 →
Change of Name
May 4, 2015
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 035571/0926 →
Confirmatory License
Feb 18, 2023
From: MASSACHUSETTS GENERAL HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 062737/0709 →